Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network
Pauline Gandolfo(Inserm), Joëlle Micallef(Assistance Publique Hôpitaux de Marseille), Élisabeth Frauger(Inserm), Bruno Revol(Centre Hospitalier Universitaire de Grenoble), Thomas Soeiro(Inserm), Céline Eiden(Centre Hospitalier Universitaire de Montpellier), Célian Bertin(Centre Hospitalier Universitaire de Clermont-Ferrand), Amélie Daveluy(Centre Hospitalier Universitaire de Bordeaux), Leïla Chaouachi, Maryse Lapeyre‐Mestre(Université Fédérale de Toulouse Midi-Pyrénées), Aurélie Aquizerate(Centre Hospitalier Universitaire de Nantes), Clémence Lacroix(Inserm), Élisabeth Jouve(Inserm), Valérie Gibaja(Centre Hospitalier Régional et Universitaire de Nancy), Louise Carton(Centre Hospitalier Universitaire de Lille), Marie‐Christine Pérault‐Pochat(Centre Hospitalier Universitaire de Poitiers), Reynald Le Boisselier(Centre Hospitalier Universitaire de Caen Normandie)
Cited by 13
Related Papers
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Non-targeted screening for novel psychoactive substances among agitated emergency department patients
|Clinical Toxicology|2016|42